Multiple dose clinical trial (sequential x 72 hour applications)
• World’s first patch to deliver therapeutic levels of oxymorphone transdermally
• 2 sequential patch application (in n=12), mean CMAX increases, Consistent delivery profile, Well tolerated, minimal irritation
• 75% less oxymorphone required for pain administration vs. oxymorphone ER oral tablets over the same 72 hour period
Multiple dose clinical trial (sequential x 72 hour applications)...
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $9.508M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.439K | 479.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 81795927 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 33320021 | 21 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.3¢ |
Change
-0.001 ( 14.3 %) |
||||
| Open | High | Low | Volume | ||
| 0.4¢ | 0.4¢ | 0.3¢ | 215316 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| AVE (ASX) Chart |